Limits...
Novel lines of Pax6-/- embryonic stem cells exhibit reduced neurogenic capacity without loss of viability.

Quinn JC, Molinek M, Nowakowski TJ, Mason JO, Price DJ - BMC Neurosci (2010)

Bottom Line: The new lines of Pax6-/-ES cells showed reduced neurogenic potential, mimicking the effects of loss of Pax6 in vivo.We suggest that loss of Pax6 from ES cells reduces their neurogenic capacity but does not necessarily result in the death of derived neurons.We offer these new lines as additional tools for those interested in the generation of chimeras and the analysis of in vitro ES cell models of Pax6 function during neuronal differentiation, embryonic and postnatal development.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre for Integrative Physiology, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD, UK. jquinn@csu.edu.au

ABSTRACT

Background: Embryonic stem (ES) cells can differentiate into all cell types and have been used extensively to study factors affecting neuronal differentiation. ES cells containing mutations in known genes have the potential to provide useful in vitro models for the study of gene function during neuronal differentiation. Recently, mouse ES cell lines lacking the neurogenic transcription factor Pax6 were reported; neurons derived from these Pax6-/- ES cells died rapidly after neuronal differentiation in vitro.

Results: Here we report the derivation of new lines of Pax6-/- ES cells and the assessment of their ability to survive and differentiate both in vitro and in vivo. Neurons derived from our new Pax6-/- lines were viable and continued to elaborate processes in culture under conditions that resulted in the death of neurons derived from previously reported Pax6-/- ES cell lines. The new lines of Pax6-/-ES cells showed reduced neurogenic potential, mimicking the effects of loss of Pax6 in vivo. We used our new lines to generate Pax6-/- <--> Pax6+/+ chimeras in which the mutant cells survived and displayed the same phenotypes as Pax6-/- cells in Pax6-/- <--> Pax6+/+ chimeras made by embryo aggregation.

Conclusions: We suggest that loss of Pax6 from ES cells reduces their neurogenic capacity but does not necessarily result in the death of derived neurons. We offer these new lines as additional tools for those interested in the generation of chimeras and the analysis of in vitro ES cell models of Pax6 function during neuronal differentiation, embryonic and postnatal development.

Show MeSH

Related in: MedlinePlus

Neurons from Pax6-/- ES cell lines remain viable and continue to elaborate processes after 16 Days in culture. (A) Wild-type wtMM4 cells and (B) Pax6-/- cells from the SeyD1 and (C) SeyD2 lines labeled for β-III-tubulin (green) and GFAP (red), with TOPRO-3 counterstaining (blue). Cells derived from all three ES cell lines are viable and have continued to make elaborate processes.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2837049&req=5

Figure 6: Neurons from Pax6-/- ES cell lines remain viable and continue to elaborate processes after 16 Days in culture. (A) Wild-type wtMM4 cells and (B) Pax6-/- cells from the SeyD1 and (C) SeyD2 lines labeled for β-III-tubulin (green) and GFAP (red), with TOPRO-3 counterstaining (blue). Cells derived from all three ES cell lines are viable and have continued to make elaborate processes.

Mentions: To determine cell viability after longer periods in culture, we allowed cells derived from our Pax6+/+, Pax6-/- SeyD1 and SeyD2 lines to continue to grow in culture to Day 16 post LIF withdrawal. At this time under comparable culture conditions, neurons derived from previously reported Pax6-/- ES cell lines had all died [11]. In contrast, neurons derived from our Pax6-/- SeyD1 and D2 lines continued to elaborate large meshworks of β-III-tubulin-positive processes (Figure 6) showing no noticeable loss of viability after 16 days in culture.


Novel lines of Pax6-/- embryonic stem cells exhibit reduced neurogenic capacity without loss of viability.

Quinn JC, Molinek M, Nowakowski TJ, Mason JO, Price DJ - BMC Neurosci (2010)

Neurons from Pax6-/- ES cell lines remain viable and continue to elaborate processes after 16 Days in culture. (A) Wild-type wtMM4 cells and (B) Pax6-/- cells from the SeyD1 and (C) SeyD2 lines labeled for β-III-tubulin (green) and GFAP (red), with TOPRO-3 counterstaining (blue). Cells derived from all three ES cell lines are viable and have continued to make elaborate processes.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2837049&req=5

Figure 6: Neurons from Pax6-/- ES cell lines remain viable and continue to elaborate processes after 16 Days in culture. (A) Wild-type wtMM4 cells and (B) Pax6-/- cells from the SeyD1 and (C) SeyD2 lines labeled for β-III-tubulin (green) and GFAP (red), with TOPRO-3 counterstaining (blue). Cells derived from all three ES cell lines are viable and have continued to make elaborate processes.
Mentions: To determine cell viability after longer periods in culture, we allowed cells derived from our Pax6+/+, Pax6-/- SeyD1 and SeyD2 lines to continue to grow in culture to Day 16 post LIF withdrawal. At this time under comparable culture conditions, neurons derived from previously reported Pax6-/- ES cell lines had all died [11]. In contrast, neurons derived from our Pax6-/- SeyD1 and D2 lines continued to elaborate large meshworks of β-III-tubulin-positive processes (Figure 6) showing no noticeable loss of viability after 16 days in culture.

Bottom Line: The new lines of Pax6-/-ES cells showed reduced neurogenic potential, mimicking the effects of loss of Pax6 in vivo.We suggest that loss of Pax6 from ES cells reduces their neurogenic capacity but does not necessarily result in the death of derived neurons.We offer these new lines as additional tools for those interested in the generation of chimeras and the analysis of in vitro ES cell models of Pax6 function during neuronal differentiation, embryonic and postnatal development.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre for Integrative Physiology, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD, UK. jquinn@csu.edu.au

ABSTRACT

Background: Embryonic stem (ES) cells can differentiate into all cell types and have been used extensively to study factors affecting neuronal differentiation. ES cells containing mutations in known genes have the potential to provide useful in vitro models for the study of gene function during neuronal differentiation. Recently, mouse ES cell lines lacking the neurogenic transcription factor Pax6 were reported; neurons derived from these Pax6-/- ES cells died rapidly after neuronal differentiation in vitro.

Results: Here we report the derivation of new lines of Pax6-/- ES cells and the assessment of their ability to survive and differentiate both in vitro and in vivo. Neurons derived from our new Pax6-/- lines were viable and continued to elaborate processes in culture under conditions that resulted in the death of neurons derived from previously reported Pax6-/- ES cell lines. The new lines of Pax6-/-ES cells showed reduced neurogenic potential, mimicking the effects of loss of Pax6 in vivo. We used our new lines to generate Pax6-/- <--> Pax6+/+ chimeras in which the mutant cells survived and displayed the same phenotypes as Pax6-/- cells in Pax6-/- <--> Pax6+/+ chimeras made by embryo aggregation.

Conclusions: We suggest that loss of Pax6 from ES cells reduces their neurogenic capacity but does not necessarily result in the death of derived neurons. We offer these new lines as additional tools for those interested in the generation of chimeras and the analysis of in vitro ES cell models of Pax6 function during neuronal differentiation, embryonic and postnatal development.

Show MeSH
Related in: MedlinePlus